{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T17:45:12Z","timestamp":1762623912338},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T00:00:00Z","timestamp":1503964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T00:00:00Z","timestamp":1503964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Exposure-based psychological treatments for anxiety have high efficacy. However, a substantial proportion of patients do not respond to therapy. Research examining the potential biological underpinnings of therapy response is still in its infancy, and most studies have focussed on candidate genes. To our knowledge, this study represents the first investigation of genome-wide expression profiles with respect to treatment outcome. Participants (<jats:italic>n<\/jats:italic>=102) with panic disorder or specific phobia received exposure-based cognitive behavioural therapy. Treatment outcome was defined as percentage reduction from baseline in clinician-rated severity of their primary anxiety diagnosis at post treatment and 6 month follow-up. Gene expression was determined from whole blood samples at three time points using the Illumina HT-12v4 BeadChip microarray. Linear regression models tested the association between treatment outcome and changes in gene expression from pre-treatment to post treatment, and pre-treatment to follow-up. Network analysis was conducted using weighted gene co-expression network analysis, and change in the detected modules from pre-treatment to post treatment and follow-up was tested for association with treatment outcome. No changes in gene expression were significantly associated with treatment outcomes when correcting for multiple testing (<jats:italic>q<\/jats:italic>&lt;0.05), although a small number of genes showed a suggestive association with treatment outcome (<jats:italic>q<\/jats:italic>&lt;0.5,<jats:italic>n<\/jats:italic>=20). Network analysis showed no association between treatment outcome and change in gene expression for any module. We report suggestive evidence for the role of a small number of genes in treatment outcome. Although preliminary, these findings contribute to a growing body of research suggesting that response to psychological therapies may be associated with changes at a biological level.<\/jats:p>","DOI":"10.1038\/tp.2017.177","type":"journal-article","created":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T13:42:06Z","timestamp":1504014126000},"page":"e1219-e1219","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Genome-wide expression and response to exposure-based psychological therapy for anxiety disorders"],"prefix":"10.1038","volume":"7","author":[{"given":"S","family":"Roberts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C C Y","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Breen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J R I","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"De Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"J\u00f6hren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Keers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S H","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Margraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Teismann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Wannem\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K J","family":"Lester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T C","family":"Eley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,29]]},"reference":[{"key":"BFtp2017177_CR1","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE . Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 2005; 62: 593\u2013602.","journal-title":"Arch Gen Psychiatry"},{"key":"BFtp2017177_CR2","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1177\/0269881113495118","volume":"27","author":"NA Fineberg","year":"2013","unstructured":"Fineberg NA, Haddad PM, Carpenter L, Gannon B, Sharpe R, Young AH et al. The size, burden and cost of disorders of the brain in the UK. J Psychopharmacol 2013; 27: 761\u2013770.","journal-title":"J Psychopharmacol"},{"key":"BFtp2017177_CR3","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1176\/appi.ajp.157.5.669","volume":"157","author":"MV Mendlowicz","year":"2000","unstructured":"Mendlowicz MV, Stein MB . Quality of life in individuals with anxiety disorders. Am J Psychiatry 2000; 157: 669\u2013682.","journal-title":"Am J Psychiatry"},{"key":"BFtp2017177_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/wps.20038","volume":"12","author":"P Cuijpers","year":"2013","unstructured":"Cuijpers P, Sijbrandij M, Koole SL, Andersson G, Beekman AT, Reynolds CF . The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons. World Psychiatry 2013; 12: 137\u2013148.","journal-title":"World Psychiatry"},{"key":"BFtp2017177_CR5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/01.nmd.0000253843.70149.9a","volume":"195","author":"PJ Norton","year":"2007","unstructured":"Norton PJ, Price EC . A meta-analytic review of adult cognitive-behavioral treatment outcome across the anxiety disorders. J Nerv Ment Dis 2007; 195: 521\u2013531.","journal-title":"J Nerv Ment Dis"},{"key":"BFtp2017177_CR6","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1037\/a0016032","volume":"77","author":"RE Stewart","year":"2009","unstructured":"Stewart RE, Chambless DL . Cognitive\u2013behavioral therapy for adult anxiety disorders in clinical practice: a meta-analysis of effectiveness studies. J Consult Clin Psychol 2009; 77: 595\u2013606.","journal-title":"J Consult Clin Psychol"},{"key":"BFtp2017177_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cpr.2005.07.003","volume":"26","author":"AC Butler","year":"2006","unstructured":"Butler AC, Chapman JE, Forman EM, Beck AT . The empirical status of cognitive-behavioral therapy: A review of meta-analyses. Clin Psychol Rev 2006; 26: 17\u201331.","journal-title":"Clin Psychol Rev"},{"key":"BFtp2017177_CR8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.psc.2010.04.002","volume":"33","author":"BO Olatunji","year":"2010","unstructured":"Olatunji BO, Cisler JM, Deacon BJ . Efficacy of cognitive behavioral therapy for anxiety disorders: a review of meta-analytic findings. Psychiatr Clin North Am 2010; 33: 557\u2013577.","journal-title":"Psychiatr Clin North Am"},{"key":"BFtp2017177_CR9","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/da.22292","volume":"31","author":"TC Eley","year":"2014","unstructured":"Eley TC . The future of therapygenetics: where will studies predicting psychological treatment response from genomic markers lead? Depress Anxiety 2014; 31: 617\u2013620.","journal-title":"Depress Anxiety"},{"key":"BFtp2017177_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/2045-5380-3-4","volume":"3","author":"KJ Lester","year":"2013","unstructured":"Lester KJ, Eley TC . Therapygenetics: using genetic markers to predict response to psychological treatment for mood and anxiety disorders. Biol Mood Anxiety Disord 2013; 3: 4.","journal-title":"Biol Mood Anxiety Disord"},{"key":"BFtp2017177_CR11","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1038\/tp.2012.140","volume":"3","author":"N Perroud","year":"2013","unstructured":"Perroud N, Salzmann A, Prada P, Nicastro R, Hoeppli M, Furrer S et al. Response to psychotherapy in borderline personality disorder and methylation status of the BDNF gene. Transl Psychiatry 2013; 3: e207.","journal-title":"Transl Psychiatry"},{"key":"BFtp2017177_CR12","doi-asserted-by":"publisher","first-page":"e444","DOI":"10.1038\/tp.2014.83","volume":"4","author":"S Roberts","year":"2014","unstructured":"Roberts S, Lester KJ, Hudson JL, Rapee RM, Creswell C, Cooper PJ et al. Serotonin transporter methylation and response to cognitive behaviour therapy in children with anxiety disorders. Transl Psychiatry 2014; 4: e444.","journal-title":"Transl Psychiatry"},{"key":"BFtp2017177_CR13","doi-asserted-by":"publisher","first-page":"e773","DOI":"10.1038\/tp.2016.41","volume":"6","author":"C Ziegler","year":"2016","unstructured":"Ziegler C, Richter J, Mahr M, Gajewska A, Schiele MA, Gehrmann A et al. MAOA gene hypomethylation in panic disorder[mdash]reversibility of an epigenetic risk pattern by psychotherapy. Transl Psychiatry 2016; 6: e773.","journal-title":"Transl Psychiatry"},{"key":"BFtp2017177_CR14","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/da.22430","volume":"32","author":"S Roberts","year":"2015","unstructured":"Roberts S, Keers R, Lester KJ, Coleman JRI, Breen G, Arendt K et al. HPA axis related genes and response to psychological therapies: genetics and epigenetics. Depress Anxiety 2015; 32: 861\u2013870.","journal-title":"Depress Anxiety"},{"key":"BFtp2017177_CR15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fpsyt.2013.00118","volume":"4","author":"R Yehuda","year":"2013","unstructured":"Yehuda R, Daskalakis NP, Desarnaud F, Makotkine I, Lehrner A, Koch E et al. Epigenetic biomarkers as predictors and correlates of symptom improvement following psychotherapy in combat veterans with PTSD. Front Psychiatry 2013; 4: 118.","journal-title":"Front Psychiatry"},{"key":"BFtp2017177_CR16","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.biopsych.2013.05.017","volume":"74","author":"E Levy-Gigi","year":"2013","unstructured":"Levy-Gigi E, Szab\u00f3 C, Kelemen O, K\u00e9ri S . Association among clinical response, hippocampal volume, and FKBP5 gene expression in individuals with posttraumatic stress disorder receiving cognitive behavioral therapy. Biol Psychiatry 2013; 74: 793\u2013800.","journal-title":"Biol Psychiatry"},{"key":"BFtp2017177_CR17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.neulet.2014.03.059","volume":"569","author":"C Szab\u00f3","year":"2014","unstructured":"Szab\u00f3 C, Kelemen O, K\u00e9ri S . Changes in FKBP5 expression and memory functions during cognitive\u2013behavioral therapy in posttraumatic stress disorder: a preliminary study. Neurosci Lett 2014; 569: 116\u2013120.","journal-title":"Neurosci Lett"},{"key":"BFtp2017177_CR18","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jad.2014.04.030","volume":"164","author":"S K\u00e9ri","year":"2014","unstructured":"K\u00e9ri S, Szab\u00f3 C, Kelemen O . Blood biomarkers of depression track clinical changes during cognitive-behavioral therapy. J Affect Disord 2014; 164: 118\u2013122.","journal-title":"J Affect Disord"},{"key":"BFtp2017177_CR19","doi-asserted-by":"publisher","first-page":"e442","DOI":"10.1038\/tp.2014.66","volume":"4","author":"EE Redei","year":"2014","unstructured":"Redei EE, Andrus BM, Kwasny MJ, Seok J, Cai X, Ho J et al. Blood transcriptomic biomarkers in adult primary care patients with major depressive disorder undergoing cognitive behavioral therapy. Transl Psychiatry 2014; 4: e442.","journal-title":"Transl Psychiatry"},{"key":"BFtp2017177_CR20","volume-title":"Diagnostisches Interview bei Psychischen St\u00f6rungen (DIPS)","author":"S Schneider","year":"2006","unstructured":"Schneider S, Margraf J, Barlow D, DiNardo P, Becker E . Diagnostisches Interview bei Psychischen St\u00f6rungen (DIPS). Springer: Berlin, 2006."},{"key":"BFtp2017177_CR21","volume-title":"DIPS: Diagnostisches Interview bei Psychischen St\u00f6rungen","author":"J Margraf","year":"2013","unstructured":"Margraf J, Schneider S, Ehlers A . DIPS: Diagnostisches Interview bei Psychischen St\u00f6rungen. Springer-Verlag: Berlin, 2013."},{"key":"BFtp2017177_CR22","doi-asserted-by":"crossref","unstructured":"Margraf J . Diagnostisches Kurz-Interview bei psychischen Stoerungen (Testmappe mit Handbuch und Interviewleitfaden). Springer: Berlin, 1994 (Mini-DIPS).","DOI":"10.1007\/978-3-662-06753-6"},{"key":"BFtp2017177_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1026\/1616-3443.37.1.33","volume":"37","author":"T In-Albon","year":"2008","unstructured":"In-Albon T, Suppiger A, Schlup B, Wendler S, Margraf J, Schneider S . Validit\u00e4t des Diagnostischen Interviews bei psychischen St\u00f6rungen (DIPS f\u00fcr DSM-IV-TR). Zeitschrift klinische Psychol Psychother 2008; 37: 33\u201342.","journal-title":"Zeitschrift klinische Psychol Psychother"},{"key":"BFtp2017177_CR24","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.beth.2011.02.003","volume":"42","author":"K Bruchm\u00fcller","year":"2011","unstructured":"Bruchm\u00fcller K, Margraf J, Suppiger A, Schneider S . Popular or unpopular? Therapists\u2019 use of structured interviews and their estimation of patient acceptance. Behav Ther 2011; 42: 634\u2013643.","journal-title":"Behav Ther"},{"key":"BFtp2017177_CR25","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.beth.2008.07.002","volume":"40","author":"A Suppiger","year":"2009","unstructured":"Suppiger A, In-Albon T, Hendriksen S, Hermann E, Margraf J, Schneider S . Acceptance of structured diagnostic interviews for mental disorders in clinical practice and research settings. Behav Ther 2009; 40: 272\u2013279.","journal-title":"Behav Ther"},{"key":"BFtp2017177_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1159\/000169699","volume":"18","author":"A Suppiger","year":"2008","unstructured":"Suppiger A, In-Albon T, Herren C, Bader K, Schneider S, Margraf J . Reliabilit\u00e4t des Diagnostischen Interviews bei Psychischen St\u00f6rungen (DIPS f\u00fcr DSM-IV-TR) unter klinischen Routinebedingungen. Verhaltenstherapie 2008; 18: 237\u2013244.","journal-title":"Verhaltenstherapie"},{"key":"BFtp2017177_CR27","first-page":"177","volume":"36","author":"A Wannem\u00fcller","year":"2015","unstructured":"Wannem\u00fcller A, Sartory G, J\u00f6hren H-P, Margraf J . Ein F\u00fcnf-Sitzungsprogramm zur Behandlung von Zahnbehandlungsangst. Verhaltenstherapie Verhaltensmedizin 2015; 36: 177\u2013196.","journal-title":"Verhaltenstherapie Verhaltensmedizin"},{"key":"BFtp2017177_CR28","unstructured":"Guy W . ECDU Asessment Manual for Psychopharmacology, Revised. US Department of Health, Education, and Welfare: Bethesda. 1976."},{"key":"BFtp2017177_CR29","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1093\/nar\/gkn234","volume":"36","author":"L-H Ding","year":"2008","unstructured":"Ding L-H, Xie Y, Park S, Xiao G, Story MD . Enhanced identification and biological validation of differential gene expression via Illumina whole-genome expression arrays through the use of the model-based background correction methodology. Nucleic Acids Res 2008; 36: e58.","journal-title":"Nucleic Acids Res"},{"key":"BFtp2017177_CR30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/1471-2164-11-349","volume":"11","author":"R Schmid","year":"2010","unstructured":"Schmid R, Baum P, Ittrich C, Fundel-Clemens K, Huber W, Brors B et al. Comparison of normalization methods for Illumina BeadChip HumanHT-12 v3. BMC Genomics 2010; 11: 349.","journal-title":"BMC Genomics"},{"key":"BFtp2017177_CR31","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/bioinformatics\/btn224","volume":"24","author":"P Du","year":"2008","unstructured":"Du P, Kibbe WA, Lin SM . lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008; 24: 1547\u20131548.","journal-title":"Bioinformatics"},{"key":"BFtp2017177_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1752-0509-6-63","volume":"6","author":"MC Oldham","year":"2012","unstructured":"Oldham MC, Langfelder P, Horvath S . Network methods for describing sample relationships in genomic datasets: application to Huntington\u2019s disease. BMC Syst Biol 2012; 6: 63.","journal-title":"BMC Syst Biol"},{"key":"BFtp2017177_CR33","volume-title":"R: A Language and Environment for Statistical Computing","author":"RC Team","year":"2015","unstructured":"Team RC . R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria, 2015."},{"key":"BFtp2017177_CR34","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"WE Johnson","year":"2007","unstructured":"Johnson WE, Li C, Rabinovic A . Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007; 8: 118\u2013127.","journal-title":"Biostatistics"},{"key":"BFtp2017177_CR35","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.csda.2013.02.005","volume":"71","author":"D Eddelbuettel","year":"2014","unstructured":"Eddelbuettel D, Sanderson C . RcppArmadillo: Accelerating R with high-performance C++ linear algebra. Comput Stat Data Anal 2014; 71: 1054\u20131063.","journal-title":"Comput Stat Data Anal"},{"key":"BFtp2017177_CR36","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1093\/bioinformatics\/btt351","volume":"29","author":"R Gaujoux","year":"2013","unstructured":"Gaujoux R, Seoighe C . CellMix: a comprehensive toolbox for gene expression deconvolution. Bioinformatics 2013; 29: 2211\u20132212.","journal-title":"Bioinformatics"},{"key":"BFtp2017177_CR37","doi-asserted-by":"publisher","first-page":"e6098","DOI":"10.1371\/journal.pone.0006098","volume":"4","author":"AR Abbas","year":"2009","unstructured":"Abbas AR, Wolslegel K, Seshasayee D, Modrusan Z, Clark HF . Deconvolution of blood microarray data identifies cellular activation patterns in systemic lupus erythematosus. PLoS ONE 2009; 4: e6098.","journal-title":"PLoS ONE"},{"key":"BFtp2017177_CR38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/15622975.2016.1208841","volume":"18","author":"JRI Coleman","year":"2016","unstructured":"Coleman JRI, Lester KJ, Roberts S, Keers R, Lee Sh, De Jong S et al. Separate and combined effects of genetic variants and pre-treatment whole blood gene expression on response to exposure-based cognitive behavioural therapy for anxiety disorders. World J Biol Psychiatry 2016; 18: 215\u2013226.","journal-title":"World J Biol Psychiatry"},{"key":"BFtp2017177_CR39","unstructured":"StataCorp Stata Statistical Software: Release 11. StataCorp LP: College Station, TX, 2009."},{"key":"BFtp2017177_CR40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1471-2105-10-48","volume":"10","author":"E Eden","year":"2009","unstructured":"Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z . GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics 2009; 10: 48.","journal-title":"BMC Bioinformatics"},{"key":"BFtp2017177_CR41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y . Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol 1995; 57: 289\u2013300.","journal-title":"J R Stat Soc Ser B Methodol"},{"key":"BFtp2017177_CR42","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S . WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008; 9: 559.","journal-title":"BMC Bioinformatics"},{"key":"BFtp2017177_CR43","doi-asserted-by":"publisher","first-page":"e1001057","DOI":"10.1371\/journal.pcbi.1001057","volume":"7","author":"P Langfelder","year":"2011","unstructured":"Langfelder P, Luo R, Oldham MC, Horvath S . Is my network module preserved and reproducible. PLoS Comput Biol 2011; 7: e1001057.","journal-title":"PLoS Comput Biol"},{"key":"BFtp2017177_CR44","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar R, Domrachev M, Lash AE . Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002; 30: 207\u2013210.","journal-title":"Nucleic Acids Res"},{"key":"BFtp2017177_CR45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neubiorev.2014.11.005","volume":"48","author":"A Rajasekaran","year":"2015","unstructured":"Rajasekaran A, Venkatasubramanian G, Berk M, Debnath M . Mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications. Neurosci Biobehav Rev 2015; 48: 10\u201321.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFtp2017177_CR46","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1073\/pnas.1423573112","volume":"112","author":"JA Santiago","year":"2015","unstructured":"Santiago JA, Potashkin JA . Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson\u2019s disease. Proc Natl Acad Sci USA 2015; 112: 2257\u20132262.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtp2017177_CR47","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1083\/jcb.200305129","volume":"163","author":"T Bisogno","year":"2003","unstructured":"Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A et al. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 2003; 163: 463\u2013468.","journal-title":"J Cell Biol"},{"key":"BFtp2017177_CR48","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1124\/mol.113.085217","volume":"84","author":"T Jain","year":"2013","unstructured":"Jain T, Wager-Miller J, Mackie K, Straiker A . Diacylglycerol Lipase\u03b1 (DAGL\u03b1) and DAGL\u03b2 cooperatively regulate the production of 2-arachidonoyl glycerol in autaptic hippocampal neurons. Mol Pharmacol 2013; 84: 296\u2013302.","journal-title":"Mol Pharmacol"},{"key":"BFtp2017177_CR49","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.phrs.2007.09.006","volume":"56","author":"P Lafen\u00eatre","year":"2007","unstructured":"Lafen\u00eatre P, Chaouloff F, Marsicano G . The endocannabinoid system in the processing of anxiety and fear and how CB1 receptors may modulate fear extinction. Pharmacol Res 2007; 56: 367\u2013381.","journal-title":"Pharmacol Res"},{"key":"BFtp2017177_CR50","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1600-0447.2011.01687.x","volume":"124","author":"CH Ashton","year":"2011","unstructured":"Ashton CH, Moore PB . Endocannabinoid system dysfunction in mood and related disorders. Acta Psychiatr Scand 2011; 124: 250\u2013261.","journal-title":"Acta Psychiatr Scand"},{"key":"BFtp2017177_CR51","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1177\/0269881111408958","volume":"26","author":"S Ruehle","year":"2012","unstructured":"Ruehle S, Rey AA, Remmers F, Lutz B . The endocannabinoid system in anxiety, fear memory and habituation. J Psychopharmacol 2012; 26: 23\u201339.","journal-title":"J Psychopharmacol"},{"key":"BFtp2017177_CR52","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1016\/j.psyneuen.2013.08.004","volume":"38","author":"MN Hill","year":"2013","unstructured":"Hill MN, Bierer LM, Makotkine I, Golier JA, Galea S, McEwen BS et al. Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks. Psychoneuroendocrinology 2013; 38: 2952\u20132961.","journal-title":"Psychoneuroendocrinology"},{"key":"BFtp2017177_CR53","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.psyneuen.2009.03.013","volume":"34","author":"MN Hill","year":"2009","unstructured":"Hill MN, Miller GE, Carrier EJ, Gorzalka BB, Hillard CJ . Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress. Psychoneuroendocrinology 2009; 34: 1257\u20131262.","journal-title":"Psychoneuroendocrinology"},{"key":"BFtp2017177_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.expneurol.2010.03.018","volume":"224","author":"D Parolaro","year":"2010","unstructured":"Parolaro D, Realini N, Vigano D, Guidali C, Rubino T . The endocannabinoid system and psychiatric disorders. Exp Neurol 2010; 224: 3\u201314.","journal-title":"Exp Neurol"},{"key":"BFtp2017177_CR55","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.biopsych.2011.04.022","volume":"70","author":"A Busquets-Garcia","year":"2011","unstructured":"Busquets-Garcia A, Puighermanal E, Pastor A, de la Torre R, Maldonado R, Ozaita A . Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses. Biol Psychiatry 2011; 70: 479\u2013486.","journal-title":"Biol Psychiatry"},{"key":"BFtp2017177_CR56","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.phrs.2011.04.010","volume":"64","author":"NR Sciolino","year":"2011","unstructured":"Sciolino NR, Zhou W, Hohmann AG . Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats. Pharmacol Res 2011; 64: 226\u2013234.","journal-title":"Pharmacol Res"},{"key":"BFtp2017177_CR57","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/ajmg.b.32467","volume":"174","author":"KJ Lester","year":"2016","unstructured":"Lester KJ, Coleman JR, Roberts S, Keers R, Breen G, B\u00f6gels S et al. Genetic variation in the endocannabinoid system and response to cognitive behavior therapy for child anxiety disorders. Am J Med Genet B Neuropsychiatr Genetics 2016; 174: 144\u2013155.","journal-title":"Am J Med Genet B Neuropsychiatr Genetics"},{"key":"BFtp2017177_CR58","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.bbi.2010.12.001","volume":"25","author":"TC Neylan","year":"2011","unstructured":"Neylan TC, Sun B, Rempel H, Ross J, Lenoci M, O'Donovan A et al. Suppressed monocyte gene expression profile in men versus women with PTSD. Brain Behav Immun 2011; 25: 524\u2013531.","journal-title":"Brain Behav Immun"},{"key":"BFtp2017177_CR59","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.immuni.2009.09.002","volume":"31","author":"X Hu","year":"2009","unstructured":"Hu X, Ivashkiv LB . Cross-regulation of signaling pathways by interferon-\u03b3: implications for immune responses and autoimmune diseases. Immunity 2009; 31: 539\u2013550.","journal-title":"Immunity"},{"key":"BFtp2017177_CR60","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1192\/apt.bp.114.012872","volume":"21","author":"V Mondelli","year":"2015","unstructured":"Mondelli V, Dazzan P, Pariante CM . Immune abnormalities across psychiatric disorders: clinical relevance. BJPsych Adv 2015; 21: 150\u2013156.","journal-title":"BJPsych Adv"},{"key":"BFtp2017177_CR61","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.mcn.2012.10.002","volume":"53","author":"KA Jones","year":"2013","unstructured":"Jones KA, Thomsen C . The role of the innate immune system in psychiatric disorders. Mol Cell Neurosci 2013; 53: 52\u201362.","journal-title":"Mol Cell Neurosci"},{"key":"BFtp2017177_CR62","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.pharmthera.2011.01.014","volume":"130","author":"L Capuron","year":"2011","unstructured":"Capuron L, Miller AH . Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther 2011; 130: 226\u2013238.","journal-title":"Pharmacol Ther"},{"key":"BFtp2017177_CR63","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrn3564","volume":"14","author":"P Svenningsson","year":"2013","unstructured":"Svenningsson P, Kim Y, Warner-Schmidt J, Oh Y-S, Greengard P . p11 and its role in depression and therapeutic responses to antidepressants. Nat Rev Neurosci 2013; 14: 673\u2013680.","journal-title":"Nat Rev Neurosci"},{"key":"BFtp2017177_CR64","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1192\/bjp.bp.115.168229","volume":"209","author":"JRI Coleman","year":"2016","unstructured":"Coleman JRI, Lester KJ, Keers R, Roberts S, Curtis C, Arendt K et al. Genome-wide association study of response to cognitive\u2013behavioural therapy in children with anxiety disorders. Br J Psychiatry 2016; 209: 236\u2013243.","journal-title":"Br J Psychiatry"},{"key":"BFtp2017177_CR65","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ajhg.2010.01.014","volume":"86","author":"LC Schalkwyk","year":"2010","unstructured":"Schalkwyk LC, Meaburn EL, Smith R, Dempster EL, Jeffries AR, Davies MN et al. Allelic skewing of DNA methylation is widespread across the genome. Am J Hum Genet 2010; 86: 196\u2013212.","journal-title":"Am J Hum Genet"},{"key":"BFtp2017177_CR66","doi-asserted-by":"publisher","first-page":"e1000888","DOI":"10.1371\/journal.pgen.1000888","volume":"6","author":"DL Nicolae","year":"2010","unstructured":"Nicolae DL, Gamazon E, Zhang W, Duan S, Dolan ME, Cox NJ . Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet 2010; 6: e1000888.","journal-title":"PLoS Genet"},{"key":"BFtp2017177_CR67","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nn.3275","volume":"16","author":"T Klengel","year":"2013","unstructured":"Klengel T, Mehta D, Anacker C, Rex-Haffner M, Pruessner JC, Pariante CM et al. Allele-specific FKBP5 DNA demethylation mediates gene\u2013childhood trauma interactions. Nat Neurosci 2013; 16: 33\u201341.","journal-title":"Nat Neurosci"},{"key":"BFtp2017177_CR68","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.lab.2005.10.005","volume":"147","author":"CC Liew","year":"2006","unstructured":"Liew CC, Ma J, Tang HC, Zheng R, Dempsey AA . The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med 2006; 147: 126\u2013132.","journal-title":"J Lab Clin Med"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tp2017177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp2017177","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/tp.2017.177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/tp2017177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T14:53:05Z","timestamp":1719413585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp2017177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,29]]},"references-count":68,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8]]}},"alternative-id":["BFtp2017177"],"URL":"https:\/\/doi.org\/10.1038\/tp.2017.177","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,29]]},"assertion":[{"value":"4 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"GB is a consultant in pre-clinical genetics for Eli Lilly. All other authors declare no financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}